Margarita Sanchez-Beato - IDIPHISA, Hosp Univ Puerta Hierro Majadahonda

基本信息

浏览量：1

职业迁徙

个人简介

Margarita Sanchez-Beato currently works at the Grupo de Investigacion en Linfomas, Instituto de Investigacion Sanitaria Puerta de Hierro-Segovia de Arana. Margarita does research in Biotechnology and Molecular Pathology.

研究兴趣

论文共 176 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

CD8+ NKs As a Potential Biomarker of Complete Response and Survival with Lenalidomide Plus R-GDP in the R2-GDP-GOTEL Trial in Recurrent/refractory Diffuse Large B Cell Lymphoma

FRONTIERS IN IMMUNOLOGY (2024)

引用0浏览0WOS引用

Supplementary Figure 7 from SUZ12 Promotes Human Epithelial Ovarian Cancer by Suppressing Apoptosis Via Silencing HRK

Hua Li,Qi Cai, Hong Wu,Vinod Vathipadiekal,Zachary C. Dobbin,Tianyu Li,Xiang Hua,Charles N. Landen,Michael J. Birrer,Margarita Sánchez-Beato,Rugang Zhang

openalex（2023）

引用0浏览0引用

Supplementary Figure 2 from SUZ12 Promotes Human Epithelial Ovarian Cancer by Suppressing Apoptosis Via Silencing HRK

Hua Li,Qi Cai, Hong Wu,Vinod Vathipadiekal,Zachary C. Dobbin,Tianyu Li,Xiang Hua,Charles N. Landen,Michael J. Birrer,Margarita Sánchez-Beato,Rugang Zhang

openalex（2023）

引用0浏览0引用

A Genetic Profiling Guideline to Support Diagnosis and Clinical Management of Lymphomas

Margarita Sánchez-Beato,Miriam Méndez,María Guirado,Lucía Pedrosa,Silvia Sequero,Natalia Yanguas-Casás,Luis de la Cruz-Merino,Laura Gálvez,Marta Llanos,Juan Fernando García,Mariano Provencio

Clinical & translational oncology official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexicono. 5 (2023): 1043-1062

引用0浏览0WOS引用

Supplementary Data from Lenalidomide Plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis